CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 12 enrolled
Drug / intervention
BI 207127 NAdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01605461
NCT01605461Phase 1Completed
CompareCT.gov

Metabolite Profile, Excretion Balance and Pharmacokinetics of BI 207127 NA Combined With [14C]-BI 207127 NA in Healthy Adult Male Volunteers After an 800 mg Single Oral Solution Dose; a Phase I, Single-arm, Open-label Trial

Boehringer Ingelheim·interventional·Posted May 25, 2012·Updated Mar 21, 2016

In Brief

A Phase 1 clinical trial evaluating BI 207127 NA for Healthy. Completed, enrolled 12 participants across 1 site.

Detailed Summary

Phase 1 study to assess the pharmacokinetics and routes of elimination of a single oral dose of \[14C\]-BI 207127 and to characterize the metabolic profile following single dose administration.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
Collaborators--

Timeline

Phase 1CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedMay 25, 2012
Enrollment StartMay 1, 2012
Primary CompletionJun 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 14.1 years ago

Interventions

BI 207127 NAdrug

Single oral solution dose of BI 207127 NA combined with \[14C\]-BI 207127 NA